CXCR2 and central nervous system cancer: These results suggest that blockade of the CXCL8–CXCR2 signaling axis disrupts the signaling network of glioma cells adapted to the methionine-restricted microenvironment and may inhibit angiogenesis by altering energy metabolic pathways such as oxidative phosphorylation.